001067.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 48,750.00
−0.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 13.32x
- P/E 2027E
- 12.28x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.63x
- PEG TTM
- 0.45x
- Price / book
- 2.87x
- Price / sales
- 1.43x
- Price / cash flow
- 8.75x
Enterprise value
- Enterprise value
- KRW 1.19T
- EV / sales
- 1.45x
- EV / EBITDA
- 9.48x
- EV / EBIT
- 10.42x
- Market cap
- KRW 1.18T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026